Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment
The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Agence France-Presse4 天
TEVIMBRA Approved in U.S. for First-line Treatment of Advanced Esophageal Squamous Cell ...
TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...
Bayswater mum Kate Minchin travelling to US to receive groundbreaking cancer treatment
In a heart-wrenching fight against an aggressive cancer diagnosis, friends and loved ones of Kate Minchin, a 41-year-old ...
CURE4 天
FDA Approves Tevimbra Plus Chemotherapy For Some With Esophageal Cancer
The FDA approved Tevimbra with chemotherapy for adults with unresectable or metastatic esophageal squamous cell carcinoma ...
New Study Finds Breast Cancer Survivors On Chemotherapy Face Prolonged Health Challenges
A recent study shows that breast cancer survivors who undergo chemotherapy face prolonged physical decline, including fatigue ...
CURE9 天
Moving Beyond Chemotherapy: How Biomarker Testing is Changing Cancer Care
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
News Medical on MSN1 天
Novel treatment approach shows promise for advanced HPV-negative head and neck cancer
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...
MPR3 天
Tevimbra Plus Chemotherapy Approved as First-Line Tx for Advanced Esophageal Cancer
The Food and Drug Administration (FDA) has approved Tevimbra® (tislelizumab-jsgr), in combination with platinum-containing chemotherapy, for the ...